• Join our community
  • IHH@LinkedIn
  • IHH@Youtube
  • IHH@Facebook
Welcoming Fortis into our Fold
28 Feb 2019

The acquisition of Fortis Healthcare solidifies IHH Healthcare’s standing in India and its place at the forefront of global healthcare.

Fulfilling a long-term strategic plan to bolster its position in the Indian market, IHH Healthcare (IHH) finalised the successful acquisition of a 31.1 per cent stake in Fortis Healthcare along with 26 per cent equity interest in its listed subsidiary Fortis Malar Hospital on 13 November 2018.

The transformational acquisition has made headlines in India, as IHH pulled ahead of its competitors to become one of the leading private healthcare providers in the country.

“IHH has already been actively expanding and deepening our presence in our home market of India over the last few years and this acquisition is a natural progression in our expansion and plans across India. This win-win combination will make IHH the leading healthcare service provider in India, while giving Fortis Healthcare and its stakeholders certainty and clarity on the future of the group,” said Dr Tan See Leng, Managing Director and Chief Executive Officer of IHH Healthcare.

A Strategic Win

Fortis is the second largest hospital chain in India with 32 hospitals and 5,000 beds. With a strong presence in India’s northern territories, it complements IHH’s existing India Operations which comprise a network of Gleneagles Global and Continental Hospitals as well as a referral centre and a medical clinic in Southern India.

With Fortis coming into its fold, IHH today has a total of 83 hospitals and more than 15,000 beds in 12 countries.

Fortis also gives IHH an immediate boost of more than 2,600 doctors and 13,200 support staff, bringing its total staff strength from 35,000 to 55,000.

Leveraging IHH’s international execution track record and expertise and the natural synergies between India Operations and Fortis in management, administration and operations, IHH is well positioned for future growth opportunities in India.

The acquisition of a controlling stake in Fortis Healthcare, one of the leading healthcare service providers in India, represents a transformational investment for IHH and demonstrates our commitment to invest considerable resources to expand and consolidate our footprint in India. We remain confident in our ability to deliver sustainable, long-term growth and value creation for our shareholders.
- Dato Mohammed Azlan bin Hashim, Chairman of IHH Healthcare

New CEO of Fortis Healthcare

Dr Ashutosh Raghuvanshi is the new Chief Executive Officer of Fortis Healthcare starting 18 March 2019.

Dr Raghuvanshi is a seasoned healthcare professional with an illustrious career spanning over 26 years. He is a successful and well-recognised paediatric cardiac surgeon and an able administrator, known for his strong record of building and leading great teams and delivering results.

Prior to joining Fortis, Dr Raghuvanshi was with Indian healthcare group, Narayana Hrudayalaya, for over 18 years.

Dr Tan See Leng, Managing Director and Chief Executive Officer, IHH Healthcare, said, “With the healthcare industry in India witnessing a strategic paradigm shift in current times, Dr Raghuvanshi’s experience will provide strategic direction and vision to the company and will ensure that our focus on clinical excellence, outcomes, patient centricity and business results remains paramount.”

Topics:

Brands:

Related Stories

Prince Court Medical Centre Performs Malaysia’s First Kelly Procedure

On 11 August, Prince Court Medical Centre placed Malaysia firmly on the global medical tourism map by successfully performing the country’s first Kelly procedure, an advanced reconstructive surgery for rare congenital urological conditions.
28 Feb 2019
Read More

Heroes in Uniform: IHH Singapore Patient Care Assistants Save a Life Off-Duty

On 9 August, five Patient Care Associates on their way home from Singapore to Johor Bahru, came together to save a stranger’s life.
28 Feb 2019
Read More

Premier Integrated Labs Marks Opening of New Lab with Strategic MoU

On 6 August, Premier Integrated Labs celebrated a significant milestone with the grand launch of its new laboratory at CMH Specialist Hospital.
28 Feb 2019
Read More

Fortis and Agilus Accelerate Precision Cancer Diagnostics

Fortis Memorial Research Institute, Gurugram, in collaboration with Agilus Diagnostics, the diagnostics arm of Fortis Healthcare, has launched its second Ion Torrent Genexus system, marking a significant step forward in enhancing precision cancer diagnostics in India.

28 Feb 2019
Read More

Advancing Patient-centred Care with Digital Transformation

IHH Healthcare has partnered with Virtusa Corporation, a leading global provider of digital strategy and IT services, to support our digital transformation initiative across our global network.

28 Feb 2019
Read More

IHH Singapore Honoured for Corporate Giving Excellence

IHH Singapore shines bright at the prestigious National Volunteer and Philanthropy Centre (NVPC) Awards, receiving two Champion of Good awards for IHH Singapore and Mount Elizabeth Hospital, alongside four Company of Good awards presented to Mount Elizabeth Novena Hospital, Gleneagles Hospital, Parkway East Hospital and Parkway Shenton.
28 Feb 2019
Read More
HOSPITALS
PRIMARY CARE
ANCILLARY SERVICES
  • Parkway Radiology Logo
  • Acibadem Labmed Logo
  • Parkway Laboratories Logo
  • Agilus Diagnostics Logo
  • Parkway Laboratories
  • Premier Integrated Labs Logo
  • Premier Integrated Rehab Logo